Numans Health Food Holdings Company Limited Announces Major Disposal of Lenovo Group Shares

Key Highlights for Investors

• Disposal of 3,000,000 Lenovo Group Shares: On 29 May 2026, Numans Health Food Holdings (Stock Code: 2530) disposed of 3,000,000 Lenovo Group Limited shares through the open market, as part of its previously announced Disposal Mandate.
• Aggregate Consideration: The total sale generated approximately HK\$71.3 million, inclusive of stamp duty and related expenses.
• Average Disposal Price: The shares were sold at an average price of around HK\$23.75 per share.
• Remaining Stake: Following the disposal, the Company’s ownership in Lenovo Group shares decreased from 4,000,000 to 1,000,000 shares.
• Financial Impact: The Group expects to recognize an unaudited gain of approximately HK\$44.0 million, calculated as the difference between the disposal proceeds and the aggregate cost of the Lenovo Group Shares sold (about HK\$27.3 million).
• Use of Proceeds: Proceeds from the sale are intended to be used for general working capital, thereby enhancing the liquidity position of the Group.
• Listing Rules: The disposal constitutes a discloseable transaction under Chapter 14 of the Listing Rules, as the relevant percentage ratios exceed 5% but are less than 25%, triggering reporting and announcement requirements.

Details of the Disposal

The transaction was executed on the open market of the Hong Kong Stock Exchange. Due to the nature of the sale, the identities of specific buyers are not known, but all were confirmed to be third parties independent of the Company and its connected persons.

About Lenovo Group

Lenovo Group Limited, incorporated in Hong Kong and listed since 1994, is a leading global technology company. Its principal businesses include R&D, manufacturing, and sales of smart devices (such as personal computers, smartphones, and tablets), infrastructure solutions (servers, storage, edge computing, high performance computing, and software-defined infrastructure), as well as software, solutions, and services.

Strategic Rationale and Shareholder Information

• The Company’s main business is the marketing, sales, and distribution of nutritional products in the PRC, under the “Nemans” brand across several categories including algal oil DHA, probiotics, vitamins, multi-nutrients, and algal calcium products.
• The disposal provides an opportunity for the Company to realize gains on its Lenovo investment, enhancing liquidity and supporting the Group’s working capital needs.
• The transaction was conducted at prevailing market prices, and the Board considers the terms fair, reasonable, on normal commercial terms, and in the best interests of shareholders.
• Shareholders should note the significant gain from the disposal (HK\$44.0 million), which may positively impact the Company’s financial performance for the relevant period.
• Any further disposal of Lenovo Group Shares will be subject to the Company’s Disposal Mandate and future market conditions.

Potential Market Sensitivity

• Share Price Movement: The realization of a substantial gain on the Lenovo stake and improved liquidity may be price sensitive, potentially affecting the Company’s share value.
• Change in Investment Portfolio: The reduction in listed equity holdings and redeployment of capital for working capital could signal a shift in the Company’s strategic focus or risk profile.
• Ongoing Monitoring: Investors should watch for further disclosures, as additional disposals or changes in strategic direction could further impact share price and capital allocation.

Board and Shareholding

The Board comprises Mr. Wang Ping (Chairman and Executive Director), Ms. Cui Juan (Executive Director), Mr. Chan Hok Leung (Non-Executive Director), and three independent non-executive directors: Ms. Yim Wing Yee, Mr. Lau Kwok Fai Patrick, and Mr. Yu Tsz Ngo. The controlling shareholder is Far-East Fortune Management (China) Co., Ltd., owned 91% by Mr. Wang Ping and 9% by Ms. Cui Juan.

Disclaimer

This article is for informational purposes only and does not constitute investment advice. Investors should refer to official company filings and consult their financial advisors for decisions. The actual financial impact is subject to final confirmation by the Company’s auditor upon completion of the consolidated financial statements.

紐曼思健康食品控股有限公司重大出售聯想集團股份公告

投資者重點

• 出售3,000,000股聯想集團股份： 於2026年5月29日，紐曼思健康食品控股（股份代號：2530）根據早前公告的出售授權，於公開市場出售3,000,000股聯想集團有限公司股份。
• 總對價： 本次出售共套現約港幣7,130萬元（已包括印花稅及相關開支）。
• 平均出售價： 每股平均售價約為港幣23.75元。
• 剩餘持股： 出售後，公司持有的聯想集團股份由4,000,000股減至1,000,000股。
• 財務影響： 預計將錄得未經審核收益約港幣4,400萬元（以出售所得與所涉股份成本約港幣2,730萬元的差額計算）。
• 資金用途： 出售所得將用於一般營運資金，有助提升集團流動性。
• 上市規則： 本次出售按上市規則第14章屬可披露交易，相關百分比比率超過5%但少於25%，須遵守通報及公告規定。

出售詳情

是次交易於香港聯合交易所公開市場執行，因屬公開市場操作，實際買家資訊無法確定，但經查證均為獨立第三方，與本公司及其關連人士無關。

有關聯想集團簡介

聯想集團有限公司於香港註冊成立，自1994年起於聯交所上市，為全球領先科技公司。主要業務包括智能設備（個人電腦、智能手機、平板電腦）、基礎設施（伺服器、存儲、邊緣計算、高效能計算及軟件定義基礎設施）及軟件、解決方案與服務的研發、生產及銷售。

戰略理由及股東須知

• 本公司主營業務為於中國內地市場營銷、銷售及分銷自家品牌「紐曼思」系列營養產品，涵蓋藻油DHA、益生菌、維他命、多元營養素及藻鈣產品。
• 今次出售令公司可實現投資收益，增強流動性並作營運資金之用。
• 交易按市場價格執行，董事會認為條款公平合理，符合公司及全體股東整體利益。
• 股東須注意，出售錄得重大收益（約港幣4,400萬元），或有機會正面影響本期財務表現。
• 往後如有進一步出售，將按公司出售授權及市場情況決定。

潛在市場敏感事項

• 股價波動： 重大投資收益及流動性提升屬市場敏感資訊，或影響公司股價。
• 投資組合變動： 減持上市股份及資本重新配置，或反映公司策略或風險偏好轉變。
• 持續監察： 投資者應密切留意進一步公告，包括任何額外出售或策略調整。

董事會及控股股東簡介

董事會成員包括主席兼執行董事王平先生、執行董事崔娟女士、非執行董事陳學良先生及三位獨立非執行董事（嚴詠儀女士、劉國輝先生及余子傲先生）。控股股東為遠東財富管理（中國）有限公司，持股結構為王平先生91%、崔娟女士9%。

免責聲明

本文僅供參考，並不構成投資建議。投資者應以公司公告為準，並諮詢專業財務顧問。最終財務影響仍須經公司審計師審核及綜合財務報表確認。

View NUMANS Historical chart here